Clinical trials: Thalassemia Major (TM)
Thalassemia Major (TM), Thalassemia Intermedia (TI)
Beta-thalassemia and Microparticles
The results will allow us to evaluate the role of MP in the thrombo-embolic risk observed in thalassemic patients and to underline a possible difference between TM and TI.
- Conditions
- Thalassemia Major (TM), Thalassemia Intermedia (TI), Microparticles (MP)Originating From Platelets, Endothelial Cells and Monocytes
- Trial name
- NCT01284738
- Testing
- Physiopathology
- Where
- France
- Volunteers
- 33 people
- Sponsor
- Assistance Publique Hopitaux De Marseille
Osteoporosis, Thalassemia Major
Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI
An Italian Multicentric randomized, open-label therapeutic trial evaluating the efficacy and safety of Neridronate in the treatment of Osteoporosis in patients with Thalassemia Major and Severe Thalassemia Intermedia.
- Conditions
- Osteoporosis, Thalassemia Major, Thalassemia Intermedia
- Trial name
- Nerixia (NCT01140321)
- Testing
- Neridronate
- Where
- 8 sites in Italy
- Volunteers
- 120 people
- Sponsor
- Ente Ospedaliero Ospedali Galliera